Your browser doesn't support javascript.
loading
Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat diet.
Lékó, András H; Gregory-Flores, Adriana; Marchette, Renata C N; Gomez, Juan L; Vendruscolo, Janaina C M; Repunte-Canonigo, Vez; Choung, Vicky; Deschaine, Sara L; Whiting, Kimberly E; Jackson, Shelley N; Cornejo, Maria Paula; Perello, Mario; You, Zhi-Bing; Eckhaus, Michael; Rasineni, Karuna; Janda, Kim D; Zorman, Barry; Sumazin, Pavel; Koob, George F; Michaelides, Michael; Sanna, Pietro P; Vendruscolo, Leandro F; Leggio, Lorenzo.
Afiliación
  • Lékó AH; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Instit
  • Gregory-Flores A; Center on Compulsive Behaviors, Intramural Research Program, National Institutes of Health, Bethesda, MD, USA.
  • Marchette RCN; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Instit
  • Gomez JL; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Vendruscolo JCM; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Repunte-Canonigo V; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, Neuroimaging Research Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Choung V; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Deschaine SL; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Whiting KE; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Instit
  • Jackson SN; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Cornejo MP; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Instit
  • Perello M; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Instit
  • You ZB; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Eckhaus M; Translational Analytical Core, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Rasineni K; Grupo de Neurofisiología, Instituto Multidisciplinario de Biología Celular (IMBICE), Universidad Nacional La Plata (UNLP), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) y Comisión de Investigaciones Científicas de la Provincia de Buenos Aires (CIC-PBA), La Plata, Argentina.
  • Janda KD; Grupo de Neurofisiología, Instituto Multidisciplinario de Biología Celular (IMBICE), Universidad Nacional La Plata (UNLP), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) y Comisión de Investigaciones Científicas de la Provincia de Buenos Aires (CIC-PBA), La Plata, Argentina.
  • Zorman B; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Sumazin P; Pathology Service, Division of Veterinary Resources, Office of Research Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Koob GF; Research Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, USA.
  • Michaelides M; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Sanna PP; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Vendruscolo LF; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
  • Leggio L; Department of Pediatrics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Commun Biol ; 7(1): 632, 2024 May 25.
Article en En | MEDLINE | ID: mdl-38796563
ABSTRACT
The stomach-derived hormone ghrelin regulates essential physiological functions. The ghrelin receptor (GHSR) has ligand-independent actions; therefore, GHSR gene deletion may be a reasonable approach to investigate the role of this system in feeding behaviors and diet-induced obesity (DIO). Here, we investigate the effects of a long-term (12-month) high-fat (HFD) versus regular diet on obesity-related measures in global GHSR-KO and wild-type (WT) Wistar male and female rats. Our main findings are that the GHSR gene deletion protects against DIO and decreases food intake during HFD in male but not in female rats. GHSR gene deletion increases thermogenesis and brain glucose uptake in male rats and modifies the effects of HFD on brain glucose metabolism in a sex-specific manner, as assessed with small animal positron emission tomography. We use RNA-sequencing to show that GHSR-KO rats have upregulated expression of genes responsible for fat oxidation in brown adipose tissue. Central administration of a novel GHSR inverse agonist, PF-5190457, attenuates ghrelin-induced food intake, but only in male, not in female mice. HFD-induced binge-like eating is reduced by inverse agonism in both sexes. Our results support GHSR as a promising target for new pharmacotherapies for obesity.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Caracteres Sexuales / Ratas Wistar / Receptores de Ghrelina / Dieta Alta en Grasa / Obesidad Límite: Animals Idioma: En Revista: Commun Biol Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Caracteres Sexuales / Ratas Wistar / Receptores de Ghrelina / Dieta Alta en Grasa / Obesidad Límite: Animals Idioma: En Revista: Commun Biol Año: 2024 Tipo del documento: Article